Sensus Healthcare, Inc. cash flow to debt ratio of 77.65% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Sensus Healthcare, Inc.'s free cash flow has increased -129.99% from $-1.11M last year to $332.00K, signaling increasing performance

Sensus Healthcare, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Sensus Healthcare, Inc.'s debt has decreased relative to shareholder equity from 0.01 last year to 0.01 today, signaling strengthened financials

Sensus Healthcare, Inc. has negative EBITDA, making leverage ratio unreliable

Sensus Healthcare, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Sensus Healthcare, Inc.'s profit margin has decreased (-316.98%) in the last year from 15.90% to -34.50%, signaling decreasing performance

Sensus Healthcare, Inc.'s short-term assets of $45.89M exceed its short-term liabilities of $4.72M

Sensus Healthcare, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Sensus Healthcare, Inc.'s return on equity of -15.79%, is lower than 15.00%, indicating bad performance

Sensus Healthcare, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Sensus Healthcare, Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings

Sensus Healthcare, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Sensus Healthcare, Inc. has a free cash flow yield of 0.66%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Sensus Healthcare, Inc.'s yearly earnings has decreased -216.13% since last year from $6.65M to $-7.72M, signaling decreasing performance

Sensus Healthcare, Inc.'s yearly revenue has decreased -34.26% since last year from $41.81M to $27.48M, signaling decreasing performance

ROIC -17.84% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Sensus Healthcare, Inc.'s 3-year revenue CAGR of -14.86% is negative, indicating declining revenue over the past 3 years

Sensus Healthcare, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

Sensus Healthcare, Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity

Sensus Healthcare, Inc. has insufficient data to evaluate this check.

Sensus Healthcare, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sensus Healthcare, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Sensus Healthcare, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Sensus Healthcare, Inc. is undervalued relative to its fair value price of 4.70 based on Earnings Fair Value model

Sensus Healthcare, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sensus Healthcare, Inc. has a price-to-book ratio of 1.10x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Sensus Healthcare, Inc. has a price-to-sales ratio of 2.22x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue